...
mdxg-img

MiMedx Group Inc, Common Stock

MDXG

NAQ

$9.1

+$0.02

(0.22%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.33B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
15.9298
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.54M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.94
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$5.47 L
$10.14 H
$9.1

About MiMedx Group Inc, Common Stock

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameMDXGSectorS&P500
1-Week Return-0.66%-2.12%-3%
1-Month Return0.44%-3.42%-0.73%
3-Month Return48.45%-11.13%2.87%
6-Month Return34.22%-5.74%7.17%
1-Year Return1.68%3.97%25.31%
3-Year Return41.74%1.05%28.38%
5-Year Return25.17%34.37%81.89%
10-Year Return-22.42%97.88%183.27%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue359.11M248.23M258.62M267.84M321.48M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":69.12,"profit":true},{"date":"2021-12-31","value":72.02,"profit":true},{"date":"2022-12-31","value":74.58,"profit":true},{"date":"2023-12-31","value":89.52,"profit":true}]
Cost of Revenue36.39M39.33M43.28M48.32M54.63M[{"date":"2019-12-31","value":66.6,"profit":true},{"date":"2020-12-31","value":71.99,"profit":true},{"date":"2021-12-31","value":79.22,"profit":true},{"date":"2022-12-31","value":88.44,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit322.73M208.90M215.33M219.53M266.84M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":64.73,"profit":true},{"date":"2021-12-31","value":66.72,"profit":true},{"date":"2022-12-31","value":68.02,"profit":true},{"date":"2023-12-31","value":82.68,"profit":true}]
Gross Margin89.87%84.16%83.26%81.96%83.01%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":93.64,"profit":true},{"date":"2021-12-31","value":92.65,"profit":true},{"date":"2022-12-31","value":91.2,"profit":true},{"date":"2023-12-31","value":92.36,"profit":true}]
Operating Expenses326.65M253.28M220.31M244.50M229.73M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":77.54,"profit":true},{"date":"2021-12-31","value":67.45,"profit":true},{"date":"2022-12-31","value":74.85,"profit":true},{"date":"2023-12-31","value":70.33,"profit":true}]
Operating Income(3.92M)(44.37M)(5.00M)(24.97M)37.12M[{"date":"2019-12-31","value":-10.57,"profit":false},{"date":"2020-12-31","value":-119.55,"profit":false},{"date":"2021-12-31","value":-13.48,"profit":false},{"date":"2022-12-31","value":-67.28,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(4.18M)(24.09M)(7.97M)(10.04M)(12.80M)[{"date":"2019-12-31","value":-418100000,"profit":false},{"date":"2020-12-31","value":-2408600000,"profit":false},{"date":"2021-12-31","value":-796700000,"profit":false},{"date":"2022-12-31","value":-1003600000,"profit":false},{"date":"2023-12-31","value":-1279700000,"profit":false}]
Pre-Tax Income(3.40M)(61.54M)(10.04M)(29.99M)30.63M[{"date":"2019-12-31","value":-11.09,"profit":false},{"date":"2020-12-31","value":-200.9,"profit":false},{"date":"2021-12-31","value":-32.77,"profit":false},{"date":"2022-12-31","value":-97.9,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes26.58M(12.26M)247.00K206.00K(36.81M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-46.12,"profit":false},{"date":"2021-12-31","value":0.93,"profit":true},{"date":"2022-12-31","value":0.77,"profit":true},{"date":"2023-12-31","value":-138.46,"profit":false}]
Income After Taxes(29.98M)(49.28M)(10.29M)(30.20M)67.44M[{"date":"2019-12-31","value":-44.45,"profit":false},{"date":"2020-12-31","value":-73.08,"profit":false},{"date":"2021-12-31","value":-15.25,"profit":false},{"date":"2022-12-31","value":-44.78,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income From Continuous Operations(25.58M)(49.28M)(10.29M)(30.20M)4.34M[{"date":"2019-12-31","value":-589.81,"profit":false},{"date":"2020-12-31","value":-1136.36,"profit":false},{"date":"2021-12-31","value":-237.15,"profit":false},{"date":"2022-12-31","value":-696.26,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(29.98M)(49.28M)(10.29M)(30.20M)67.44M[{"date":"2019-12-31","value":-44.45,"profit":false},{"date":"2020-12-31","value":-73.08,"profit":false},{"date":"2021-12-31","value":-15.25,"profit":false},{"date":"2022-12-31","value":-44.78,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
EPS (Diluted)0.21(0.05)(0.15)(0.33)0.32[{"date":"2019-12-31","value":66.58,"profit":true},{"date":"2020-12-31","value":-15.85,"profit":false},{"date":"2021-12-31","value":-47.56,"profit":false},{"date":"2022-12-31","value":-104.63,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

MDXG
Cash Ratio 2.12
Current Ratio 4.10
Quick Ratio 3.53

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MDXG
ROA (LTM) 18.38%
ROE (LTM) 62.47%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MDXG
Debt Ratio Lower is generally better. Negative is bad. 0.26
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.74

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MDXG
Trailing PE 15.96
Forward PE 19.53
P/S (TTM) 3.90
P/B 7.39
Price/FCF 67
EV/R 3.70
EV/Ebitda 18.97
PEG 2.97

FAQs

What is MiMedx Group Inc share price today?

MiMedx Group Inc (MDXG) share price today is $9.1

Can Indians buy MiMedx Group Inc shares?

Yes, Indians can buy shares of MiMedx Group Inc (MDXG) on Vested. To buy MiMedx Group Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MDXG stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of MiMedx Group Inc be purchased?

Yes, you can purchase fractional shares of MiMedx Group Inc (MDXG) via the Vested app. You can start investing in MiMedx Group Inc (MDXG) with a minimum investment of $1.

How to invest in MiMedx Group Inc shares from India?

You can invest in shares of MiMedx Group Inc (MDXG) via Vested in three simple steps:

  • Click on Sign Up or Invest in MDXG stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in MiMedx Group Inc shares
What is MiMedx Group Inc 52-week high and low stock price?

The 52-week high price of MiMedx Group Inc (MDXG) is $10.14. The 52-week low price of MiMedx Group Inc (MDXG) is $5.47.

What is MiMedx Group Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of MiMedx Group Inc (MDXG) is 15.9298

What is MiMedx Group Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of MiMedx Group Inc (MDXG) is 7.39

What is MiMedx Group Inc dividend yield?

The dividend yield of MiMedx Group Inc (MDXG) is 0.00%

What is the Market Cap of MiMedx Group Inc?

The market capitalization of MiMedx Group Inc (MDXG) is $1.33B

What is MiMedx Group Inc’s stock symbol?

The stock symbol (or ticker) of MiMedx Group Inc is MDXG

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top